All News #Library
Others
Ascletis receives IND approval for its NASH drug
28 Aug 2019 //
BIOSPECTRUMASIA
3-V Biosciences Changes Name to Sagimet Biosciences and Closes $25 M
05 Aug 2019 //
PR NEWSWIRE
Ascletis and 3-V Biosciences Announce NASH-License and Series E Financing
12 Feb 2019 //
PR NEWSWIRE

Market Place
Sourcing Support